GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Biogen Inc (MEX:BIIB) » Definitions » Tax Rate %

Biogen (MEX:BIIB) Tax Rate % : 16.47% (As of Jun. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Biogen Tax Rate %?

Tax Rate % is calculated as Tax Expense divided by its Pre-Tax Income. Biogen's Tax Expense for the three months ended in Jun. 2024 was MXN2,109 Mil. Biogen's Pre-Tax Income for the three months ended in Jun. 2024 was MXN12,800 Mil. Therefore, Biogen's Tax Rate % for the quarter that ended in Jun. 2024 was 16.47%.

Biogen Tax Rate % Historical Data

The historical data trend for Biogen's Tax Rate % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biogen Tax Rate % Chart

Biogen Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Tax Rate %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 16.25 19.66 3.01 17.62 10.43

Biogen Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Tax Rate % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.21 51.63 14.64 15.36 16.47

Biogen Tax Rate % Calculation

Tax Rate % is the ratio of tax expense divided by pretax income, usually presented in percent.

Biogen's Tax Rate % for the fiscal year that ended in Dec. 2023 is calculated as

Tax Rate %=Tax Expense (A: Dec. 2023 )/Pre-Tax Income (A: Dec. 2023 )
=2296.616/22012.205
=10.43 %

Biogen's Tax Rate % for the quarter that ended in Jun. 2024 is calculated as

Tax Rate %=Tax Expense (Q: Jun. 2024 )/Pre-Tax Income (Q: Jun. 2024 )
=2108.644/12800.256
=16.47 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biogen Tax Rate % Related Terms

Thank you for viewing the detailed overview of Biogen's Tax Rate % provided by GuruFocus.com. Please click on the following links to see related term pages.

Biogen Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Biogen Inc (MEX:BIIB) » Definitions » Tax Rate %
Comparable Companies
OGN AMRN SCLX MIRA BMY GILD LLY JNJ ABBV MRK XSWX:ROG LSE:AZN XSWX:NOVN AMGN PFE XPAR:SAN TSE:4519 LSE:GSK TSE:4568 SHSE:600276
Traded in Other Exchanges
BIIB:USA 1BIIB:Italy 0R1B:UK IDP:Germany BIIB34:Brazil BIIB:Austria BIIB:Argentina
Address
225 Binney Street, Cambridge, MA, USA, 02142
Website
https://www.biogen.com
Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva (oncology) and Ocrevus (multiple sclerosis) are marketed via a collaboration with Roche. Biogen markets several multiple sclerosis drugs including Plegridy, Tysabri, Tecfidera, and Vumerity. Biogen's newer products include Spinraza (SMA, with partner Ionis), Leqembi (Alzheimers, with partner Eisai), Skyclarys (Friedreich's Ataxia, Reata), Zurzuvae (postpartum depression, Sage), and Qalsody (ALS, Ionis). Biogen has several drug candidates in phase 3 trials in neurology, immunology, and rare diseases.